Terms: = Head and neck cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9 AND Prognosis
5 results:
1. PI3K/Akt signalling pathway-associated long noncoding RNA signature predicts the prognosis of laryngeal cancer patients.
Nie Q; Cao H; Yang J; Liu T; Wang B
Sci Rep; 2023 Sep; 13(1):14764. PubMed ID: 37679508
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA mnx1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
Cui X; Yu H; Yu T; Xiao D; Wang X
Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA mnx1-AS1 Contributes to Laryngeal Squamous Cell Carcinoma Growth and Migration by Regulating mir-744-5p/bcl9/β-Catenin Axis.
Ma B; Ren G; Xu J; Yin C; Shi Y
Cell Transplant; 2021; 30():9636897211005682. PubMed ID: 33821684
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
5. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
Zhang G; Fan E; Zhong Q; Feng G; Shuai Y; Wu M; Chen Q; Gou X
Hum Genomics; 2019 Aug; 13(1):36. PubMed ID: 31416476
[TBL] [Abstract] [Full Text] [Related]
